Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axogen, Inc. | 260,868 | reported | 06 Jan 2025 | tx 2+300,000−39,132 |
| BRAINSTORM CELL THERAPEUTICS INC | 180,000 | reported | 26 Feb 2026 | tx 3+222,665 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | GRANT_AWARD | BRAINSTORM CELL THERAPEUTICS INC | 180,000 | 0.70 USD | deriv |
| 06 Jan 2025 | TAX_WITHHOLDING | Axogen, Inc. | 39,132 | 15.22 USD | |
| 01 Jan 2025 | GRANT_AWARD | BRAINSTORM CELL THERAPEUTICS INC | 30,666 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | Axogen, Inc. | 300,000 | — | |
| 19 Jun 2023 | GRANT_AWARD | BRAINSTORM CELL THERAPEUTICS INC | 11,999 | 0.00 USD |